Profound Medical (PROF) Non-Current Deferred Tax Liability (2023)

Profound Medical (PROF) recorded quarterly Non-Current Deferred Tax Liability of $59000.0 in Q4 2023.

Profound Medical (PROF) Non-Current Deferred Tax Liability (2023) Analysis & Trends

Profound Medical's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $59000.0 for Q4 2023.

In Q4 2023, Non-Current Deferred Tax Liability changed N/A year-over-year to $59000.0; the TTM figure through Dec 2023 stood at $59000.0 (changed N/A YoY), while the FY2023 annual figure was $59000.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability was $59000.0 for Q4 2023 at Profound Medical.
In the past five years, Non-Current Deferred Tax Liability ranged from a high of $59000.0 in Q4 2023 to a low of $59000.0 in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn
10	Profound Medical	240.29 Mn	190.00 Mn	3.83 Mn

Download Data

Date	Value
Dec 31, 2023	59,000.00
Dec 31, 2023	59,000.00